Cargando…
Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535777/ https://www.ncbi.nlm.nih.gov/pubmed/37767919 http://dx.doi.org/10.1093/toxsci/kfad070 |
| _version_ | 1785112711228555264 |
|---|---|
| author | Elmore, Susan A Rehg, Jerold E Schoeb, Trenton R Everitt, Jeffrey I Bolon, Brad |
| author_facet | Elmore, Susan A Rehg, Jerold E Schoeb, Trenton R Everitt, Jeffrey I Bolon, Brad |
| author_sort | Elmore, Susan A |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10535777 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105357772023-09-29 Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid? Elmore, Susan A Rehg, Jerold E Schoeb, Trenton R Everitt, Jeffrey I Bolon, Brad Toxicol Sci ToxPoint Oxford University Press 2023-09-28 /pmc/articles/PMC10535777/ /pubmed/37767919 http://dx.doi.org/10.1093/toxsci/kfad070 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the Society of Toxicology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
| spellingShingle | ToxPoint Elmore, Susan A Rehg, Jerold E Schoeb, Trenton R Everitt, Jeffrey I Bolon, Brad Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid? |
| title | Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid? |
| title_full | Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid? |
| title_fullStr | Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid? |
| title_full_unstemmed | Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid? |
| title_short | Is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid? |
| title_sort | is statistical re-evaluation of hemolymphoreticular neoplasms from aspartame studies valid? |
| topic | ToxPoint |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535777/ https://www.ncbi.nlm.nih.gov/pubmed/37767919 http://dx.doi.org/10.1093/toxsci/kfad070 |
| work_keys_str_mv | AT elmoresusana isstatisticalreevaluationofhemolymphoreticularneoplasmsfromaspartamestudiesvalid AT rehgjerolde isstatisticalreevaluationofhemolymphoreticularneoplasmsfromaspartamestudiesvalid AT schoebtrentonr isstatisticalreevaluationofhemolymphoreticularneoplasmsfromaspartamestudiesvalid AT everittjeffreyi isstatisticalreevaluationofhemolymphoreticularneoplasmsfromaspartamestudiesvalid AT bolonbrad isstatisticalreevaluationofhemolymphoreticularneoplasmsfromaspartamestudiesvalid |